Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域：
Cancer
Target：
IC50: 8 nM (PDGF-Rβ)
描述：
TSU-68 is a novel multiple receptor tyrosine kinase inhibitor with IC50 of 2.1 μM, 8 nM and 1.2 μM for VEGF-R1, PDGF-Rβ and FGF-R1, respectively, and has greatest potency against PDGFR autophosphoryla
m.cnreagent.com
